non-menstrual pain

November 6, 2018November 6, 2018

Linzagolix Provides Sustained Relief From Endometriosis-related Pain, Phase 2b Results Show

News

Treatment with linzagolix can effectively reduce endometriosis-associated pelvic pain and painful periods, and provide long-term symptom relief, according to the latest results of a Phase 2b clinical trial. After ... Read more

June 27, 2018June 27, 2018

Linzagolix Shows Potential to Reduce Endometriosis-Related Pain in Phase 2b Trial

News

Linzagolix can effectively reduce endometriosis-associated pain and improve patients’ health-related quality of life, according to preliminary data from the Phase 2b EDELWEISS clinical trial. Supported by these positive results, ... Read more

September 7, 2017September 7, 2017

AbbVie Files for FDA Approval of Elagolix to Treat Endometriosis-associated Pain

News

AbbVie, in collaboration with Neurocrine Biosciences, has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for its lead candidate elagolix, formerly known as ABT-620, to ... Read more

May 19, 2017May 19, 2017

Elagolix Reduces Menstrual and Non-Menstrual Endometriosis Pain, Phase 3 Studies Report

News

Final data of two large Phase 3 trials of Abbvie’s elagolix published today again found that the treatment effectively reduced pain in women with endometriosis. The findings support a ... Read more